BioMed Research International

BioMed Research International / 2018 / Article

Research Article | Open Access

Volume 2018 |Article ID 3693602 | 9 pages |

Effect of Kisspeptin on the Developmental Competence and Early Transcript Expression in Porcine Oocytes Parthenogenetically Activated with Different Methods

Academic Editor: Claude Prigent
Received06 Oct 2017
Revised10 Jan 2018
Accepted17 Jan 2018
Published21 Feb 2018


Recent studies showed the modulatory effect of kisspeptin (KP) on calcium waves through the cell membrane and inside the cell. Spermatozoon can induce similar ooplasmic calcium oscillations at fertilization to trigger meiosis II. Here, we evaluated the effect of KP supplementation with 6-dimethylaminopurine (6-DMAP) for 4 h on embryonic development after oocyte activation with single electric pulse, 5 µM ionomycin, or 8% ethanol. Compared to control nonsupplemented groups, KP significantly improved embryo developmental competence electric- and ethanol-activated oocytes in terms of cleavage (75.3% and 58.6% versus 64% and 48%, respectively, ) and blastocyst development (31.3% and 10% versus 19.3% and 4%, respectively, ). MOS expression was increased in electrically activated oocytes in presence of KP while it significantly reduced CCNB1 expression. In ionomycin treated group, both MOS and CCNB1 showed significant increase with no difference between KP and control groups. In ethanol-treated group, KP significantly reduced CCNB1 but no effect was observed on MOS expression. The early alterations in MOS and CCNB1 mRNA transcripts caused by KP may explain the significant differences in the developmental competence between the experimental groups. Kisspeptin supplementation may be adopted in protocols for porcine oocyte activation through electric current and ethanol to improve embryonic developmental competence.

1. Introduction

In mammals, meiosis II resumes in mature oocytes after fertilization and is mainly mediated by the highly repetitive calcium (Ca2+) signals that last for 2-3 h rather than a single Ca2+ rise [1, 2]. Ca2+ modulates the transition of the cell from one meiotic phase and cell cycle control checkpoints to the following phase till the extrusion of the second polar body [3]. Lack of intracellular Ca2+ elevation prevents spontaneous meiosis resumption in vitro [4]. Moreover, injection of Ca2+ in mouse oocytes has been shown to cause parthenogenetic activation and subsequent embryonic development [1].

The c-Mos (MOS) proto-oncogene is a serine/threonine kinase expressed in vertebrate oocytes and plays a crucial role in meiosis and germ cell development [5, 6]. MOS is functionally expressed during G2/M progression of oocyte cell cycle [7] and was found to be expressed highly in oocytes while it reduced with the cleavage and mitosis of the zygote [8]. MOS activates mitogen-activated protein kinase (MAPK), which in turn activates M-phase promoting factor (MPF) [6]. MPF is a protein complex comprised of a catalytic subunit with serine-threonine kinase activity and a regulatory subunit cyclin B (CCNB1). MPF is regulated by the binding of CCNB1 with cyclin-dependent kinase 1 (Cdc2) and phosphorylation of threonine 161 and dephosphorylation of tyrosine 15 and threonine 14 [9]. Notably, there is a regulatory interplay between Ca+2, MOS, and CCNB1 in a feedback manner to regulate the exit from meiosis II [1015].

Parthenogenetic activation of porcine oocytes has been carried out using different methods such as electrical stimulus, chemical activation, and ethanol treatment [1619]; however, the underlying molecular mechanism is questionable. During parthenogenesis protocols, activation is usually followed by the inhibition of protein phosphorylation with 6-dimethylaminopurine (6-DMAP), a protein kinase inhibitor, resulting in efficient oocyte activation and development of parthenotes into the blastocyst stage [20]. 6-DMAP inhibits MPF reactivation, thereby triggering a kinetic similar to that occurring after fertilization [21, 22]. However, interfering with one or several kinases involved in other cellular functions may alter the subsequent cellular events.

Interestingly, cyclin degradation is activated by fertilization; however this activation is transitory since cyclin B1 levels recover between Ca2+ oscillation spikes. Therefore, continued cyclin degradation at basal Ca2+ levels requires multiple spikes to complete meiosis II [23].

Kisspeptin (KP) is a multifunctional peptide known for its function in reproductive endocrinology, cancer, cardiovascular system, and urogenital system [24, 25]. Our previous report and other studies showed that kisspeptin receptor (KISS1R) is functional throughout the oocyte maturation until early embryonic stages [2631]. In addition, KP supplementation during in vitro maturation (IVM) increases the maternal mRNA transcripts, including that for MOS [31]. KP is thought to modulate Ca2+ oscillations through the cell membrane and inside the cell, including spermatozoa [3238]. Activation of KISS1R results in a biphasic rise in intracellular Ca2+ characterized by a short and transient phase followed by a sustained phase [37].

Therefore, this study aimed to examine whether KP, as a Ca2+ modulator, can differentially support the transition of oocytes from MII stage to further embryonic developmental stages when oocytes activated with electric stimulus, ionomycin, or ethanol through investigating the effect of KP supplementation on the expression of early maternal transcripts involved in meiotic progression, MOS and CCNB1.

2. Materials and Methods

2.1. Chemicals

Kisspeptin (112–121) amide was obtained from Phoenix Pharmaceuticals Inc. (Burlingame, CA, USA). Other chemicals were obtained from Sigma-Aldrich Corp. (St. Louis, MO, USA), unless otherwise stated.

2.2. Collection of Cumulus-Oocyte Complexes (COCs) and Their In Vitro Maturation

Ovaries obtained from a local abattoir were transported to the laboratory within 4 h in 0.9% (v/v) sodium chloride (NaCl) solution at 30–33°C. Follicular contents from antral follicles, 2–6 mm in diameter, were collected using an 18-gauge needle attached to a 10 mL sterile syringe. COCs enclosed by more than three layers of compact cumulus cells and with evenly granulated cytoplasm were selected and washed thrice with HEPES-buffered tissue culture medium-199 (TCM-199) supplemented with 2 mM sodium bicarbonate (NaHCO3), 5 mg/mL bovine serum albumin (BSA), and 1 μL/mL gentamycin sulfate (Caisson Lab. Inc., Smithfield, UT, USA). Groups of 50 COCs were cultured in four-well dishes (Falcon, Becton Dickinson Ltd., Plymouth, UK) in 500 μL maturation medium comprising bicarbonate-buffered TCM-199 supplemented with 10% (v/v) porcine follicular fluid, 10 μg/mL follicle-stimulating hormone (FSH), 1 μg/mL luteinizing hormone (LH), 1 μg/mL 17β-estradiol, 20 ng/mL epidermal growth factor (EGF), 1 μL/mL insulin-transferrin-selenium (ITS), 0.3 μM cysteamine, 0.15 mg/mL L-glutamine, and 1 μL/mL gentamycin sulfate at 39°C in a humidified atmosphere of 5% CO2 for 44 h (two stages, 22 h each with change of medium for the second stage).

2.3. Parthenogenetic Activation and KP Supplementation

After 44 h of IVM, oocytes and cumulus cells were separated by pipetting with 0.1% hyaluronidase in Dulbecco’s phosphate-buffered saline (PBS) supplemented with 0.1% polyvinyl alcohol. Denuded oocytes were randomly separated into three groups and subjected to one of the following parthenogenetic activation methods: (1) in electrical activation, oocytes were activated with a single DC pulse of 1.5 kV/cm for 100 μs in mannitol (0.25 M) using BTX Electro Cell Manipulator 2001 designed electrodes chamber (BTX, Inc., San Diego, CA, USA); (2) in ionomycin activation, oocytes were incubated in TCM-199 supplemented with 10% fetal bovine serum (FBS) and 5 μM ionomycin for 5 min in a dark chamber; or (3) in ethanol activation, oocytes were incubated in TCM-199 containing 10% FBS and 8% ethanol for 10 min. Activated oocytes were washed in TCM and cultured in 500 μL of 4 mM 6-DMAP with or without 1 μM KP for 4 h at 39°C in an atmosphere of 5% CO2, 5% O2, and 90% N2 to produce diploid zygotes.

2.4. Experimental Design

Denuded oocytes were randomly allocated into three groups, 75 oocytes each, and incubated in 50 μL microdrops of TCM-199 supplemented with 10% fetal bovine serum (FBS) for 10 min. Oocytes were then activated with specific treatment (electric, ionomycin, or ethanol activation), and then, a pool of oocytes was immediately collected from each group to extract mRNA (0 h after activation). After incubation with 6-DMAP with or without KP, another pool of oocytes was collected to extract mRNA from each group (4 h after activation batch). The remaining 25 oocytes were then used for in vitro culture. The experiment was repeated six times and the data were presented as mean ± SEM.

2.5. In Vitro Culture of Embryos

Presumptive zygotes were washed and cultured in 30 μL microdrops of porcine zygote medium-5 covered with mineral oil at 39°C in presence of 5% CO2, 5% O2, and 90% N2. Embryos were evaluated for cleavage and blastocyst formation on days 2 and 7, respectively.

2.6. Real-Time qPCR for Relative Quantification of mRNA Transcripts

Cumulus-free oocytes ( for each replicate, confirmed by visual examination of each individual oocyte) at different stages of activation were collected, washed twice with PBS, and stored at −80°C in diethylpyrocarbonate- (DEPC-) treated water until analysis. Total RNAs were extracted from all samples following the manufacturer’s protocol (iNtRON Biotechnology, Seoul, Korea). RNA concentration and purity were evaluated using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) by calculating the ratios of absorbance at 260 and 280 nm; samples showing values ≥1.8 for 260/280 were used for reverse transcription (RT). RT was carried out at 50°C for 50 min. Individual RT reaction was performed using random hexamer, 100 ng of total RNA and superscript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA) in a 20-μL reaction volume. Complementary DNA (cDNA) concentration was measured through NanoDrop spectrophotometer. Relative quantitative real-time polymerase chain reaction (qPCR) was carried out according to the Takara Bio Inc. guidelines. A total of 22 μL PCR reaction was made by adding 0.1 μg cDNA, 1 μM forward primer, 1 μM reverse primer, 8 μL SYBR Premix Ex Taq, 0.4 μL ROX reference (Takara Bio Inc. Shiga, Japan), and 9.6 μL nuclease-free water (Ambion Inc., Austin, TX, USA). The reaction was performed on 7300 Real-Time PCR System (Applied Biosystems, Forest City, CA, USA) according to the company’s instructions using the following program: 95°C for 10 min, followed by 40 cycles of 95°C for 10 s, 60°C for 20 s, and 72°C for 40 s. MOS and CCNB1 mRNA transcripts were relatively quantified, with gene for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) used as a normalization control [39] using method [ΔCt Experimental = Ct (test gene) − Ct (GAPDH); ΔCt Control = Ct (test gene) − Ct (GAPDH); and ΔΔCt = ΔCt Experimental −  ΔCt Control] [40]. Primer sequences, annealing temperatures, and approximate sizes of the amplified fragments are listed in Table 1. To determine primers specificity, melting curves for each primer pair were evaluated by Applied Biosystems 7300 Real-Time PCR apparatus-associated software and the product size was confirmed by gel electrophoresis of PCR products on agarose 1.5% referred to by 1 Kb DNA ladder. Samples from four replicates and three technical replicates were recorded for each qPCR sample reaction. Data were recorded and used for statistical analysis and presented as mean ± SEM.

GeneForward 3′→5′Reverse 3′→5′ (°C)Product size (bp)Information


2.7. Statistical Analysis

The COCs and oocytes were randomly distributed within each experimental group and experiments were repeated at least five times. Embryo development proportions were calculated for each replicate and relative quantification of transcripts was analyzed by one-way ANOVA using SAS (SAS Institute, Cary, NC, USA, 2000) which was followed by Tukey’s Multiple Range Test to determine the differences among the groups. Values were presented as means ± standard error of the mean (SEM). Data were considered statistically significant at value of .

3. Results and Discussion

Results showed that supplementation of 6-DMAP culture with KP (KP+) significantly increased embryo cleavage proportion in oocytes activated with electric pulse and ethanol (% and %, respectively) as compared with the control groups (KP−) (Table 2) with maximum effect observed with electrical activation . On the other hand, KP supplementation had no advantageous effect on the oocytes activated with ionomycin (Table 2, Figure 1). Similar trend was observed for blastocysts; KP-supplemented groups activated with electric pulse and ethanol showed a significant increase in blastocyst proportion (31.75 ± 0.9% and 10.25 ± 0.25%, respectively) as compared with control groups (Table 2, ). On the other hand, KP supplementation showed no effect on blastocyst formation in oocytes activated with ionomycin.


Oocyte 150150150150150150
Fold change of 2.51.612.
Fold change of 0.40.652.

replicates with average 25 oocytes per each replicate. The proportion of cleavage and blastocyst was calculated for each replicate and data expressed as mean ± SEM. mean of fold change in MOS and CCNB1 expression in oocytes at 0 h and 4 h after activation = expression level at 4 h divided by the expression at 0 h (values are shown in Figure 2). carrying different superscripts are considered significant when .

Additionally, a significant increase in embryo cleavage and blastocyst was observed following oocyte activation with electric pulse (% and %, respectively) and ionomycin (% and %, respectively) as compared to that in ethanol-activated oocytes (% and %, respectively, ) (Table 2, Figure 1). This is consistent with the results by Cheng et al. [16], wherein the electrical and ionomycin activation resulted in a threefold increase in developmental competence of porcine oocytes as compared with the ethanol-mediated activation. Moreover, ethanol treatment in oocytes was reported to yield a very low percentage of cleavage and blastocyst formation [19]. On the contrary, Koo et al. [41] showed that electrical activation significantly increased the cleavage and blastocyst development as compared with ionomycin activation.

Recent reports have described the mechanism of action of KP through the modulation of Ca2+ oscillation in different cell types, including spermatozoa [3236]. In addition, KP is known to cause biphasic increase in intracellular Ca2+ characterized by a short and transient phase followed by a sustained phase [37]. Following oocyte activation, the oscillation in Ca2+ signals, in particular the early Ca2+/calmodulin-dependent kinase pathways, results in the emission of the second polar body [42]. The recruitment of maternal mRNAs is thought to be a graded response to the number of Ca2+ oscillations experienced by the oocyte [43]. In addition, artificial methods of oocyte activation may result in the recruitment of the maternal mRNA in the absence of Ca2+ elevation [44], indicative of the indirect effect of Ca2+ on the process downstream of cell cycle resumption. Electric pulse showed a higher and longer Ca2+ transient in the oocyte immediately after its activation [45]. Moreover, electrical activation induces a rapid reduction in histone H1 kinase activity [46]. However, the elevation in intracellular levels of free Ca2+ by ionomycin was less effective for parthenogenetic activation of oocytes than that caused by electrical pulse [47].

Studies have reviewed the different mechanistic pathways for porcine parthenogenesis [48, 49]. In particular, electrical pulse causes influx of Ca2+ by increasing the permeability of the oolemma [50, 51], while 7% ethanol and calcium ionophores cause a surge in the intracellular Ca2+ from Ca2+ stores by increasing the intracellular pH [47, 5254]. The sodium-hydrogen (Na+/H+) antiporter and the bicarbonate-chloride (/) exchanger are suggested to play no role during calcium ionophore treatment; however, ethanol treatment in oocytes may be dependent upon either Na+ or flux (or both) [53]. On the other hand, calcium ionophores inhibit the vacuolar-type H+ ATPases, thereby increasing the intracellular pH [53]. The pH rise plays an important role in activating oocyte metabolism and increasing DNA and protein synthesis [55]. Since the Ca+2 ions have two opposing roles during Xenopus oocyte maturation, it negatively regulates meiosis entry by delaying the activation of the cell cycle machinery (downstream of protein kinase A and upstream of MOS), while on the other hand, it is required for completion of meiosis [56]. Therefore, modulation of temporal calcium influx to the ooplasm is essential for successful meiosis. The three activation methods use calcium signals as the main pathway for oocyte activation; however, how acute or repetitive calcium influx is and for how long this influx continues are questions for clarifying the difference between these methods for supporting meiosis II and early embryo development.

We investigated the possible cause of the difference between activation methods with or without KP supplementation. MOS and CCNB1 transcripts were relatively quantified through real-time PCR immediately after activation (0 h after activation), and 4 h after activation and culture in 6-DMAP (4 h after activation) with or without KP. Statistical analysis showed significant interaction among the treatments and the temporal expression of MOS and CCNB1.

It has been clarified that 6-DMAP, a phosphatase inhibitor, caused a higher and longer Ca2+ transient and may activate oocytes by changing Ca2+ oscillations in oocytes and inhibiting phosphotyrosine dephosphorylation after parthenogenetic activation [45]. However, oocytes activated with calcium ionophores and 6-DMAP displayed abnormal pattern of karyokinesis during the first cell cycle [57]. Although 6-DMAP-mediated inhibition of protein kinase is an efficient way to induce oocyte activation, interfering with one or several kinases involved in other functions may be deleterious for cellular events after activation. Therefore, we aimed to examine whether KP may act as a Ca2+ modulator during this period.

Kisspeptin supplementation after 4 h from activation resulted in differential alteration in the expression patterns of MOS and CCNB1 in different treatment groups; it significantly increased MOS expression (2.5-fold, Table 2) when compared with both control (KP−) and 0 h after activation in electrically activated oocytes (; Figures 2(a) and 2(b)). In ethanol-treated group, KP significantly decreased the level of CCNB1 by 0.3-fold when compared with 0 h after activation and control nonsupplemented group ; however, no effect was observed on MOS (Figures 2(e) and 2(f)). On the other hand, oocytes treated with ionomycin showed no difference on MOS and CCNB1 both with and without KP supplementation , although MOS and CCNB1 expressions significantly increased (~2.5-fold) after 4 h from activation (Figures 2(c) and 2(d), ).

Some reports showed that mRNA expression of proto-oncogenes (such as MYC) is tightly and coordinately regulated and rapidly turned over with half-lives of 9–40 min [23, 58, 59]. Moreover, transcription rates for transiently expressed genes and mRNA stability are often rapidly and coordinately affected by calcium-dependent signaling pathways [60, 61]. These observations might explain the rapid transcriptional changes in proto-oncogene MOS and CCNB1 associated with oocyte stimulation and its incubation with calcium modulator, KP.

The early changes in cyclin B and c-Mos complexes are critical for pronuclear formation; after oocyte fertilization or parthenogenetic activation, an increase in intracellular Ca2+ causes degradation of c-Mos protein, inactivation of cytostatic factor (CSF) and MPF, and release of eggs from meiotic metaphase arrest [62]. These results suggest that the early changes in MOS and CCNB1 may influence the embryonic developmental competence, including cleavage and subsequent mitosis stages until the blastocyst formation. On the other hand, Lazar et al. [63] clarified that MOS mRNA expression is associated with meiosis progression and occurs independent of MAPK. In addition, Koo et al. [41] showed inactivation of MPF and MAPK after oocyte activation with single electrical stimulus.

In the current study, KP increased the level of MOS (2.5-fold) in electrically activated oocytes, highlighting the need of MOS for successful completion of cell cycle progression after activation [6, 7]. Moreover, supplementation of the electrically or ethanol-activated oocytes with KP significantly reduced the level of CCNB1 transcript, which is essential for MPF inhibition to allow meiosis II to proceed [9]. Interestingly, the interplay between MOS and CCNB1 plays an important role during meiosis in mammalian oocytes [1015]. Physiologically, a spermatozoa Ca2+ signal induces degradation of cyclin B1 which in turn results in exit of oocyte from metaphase II arrest and permits extruding the second polar body [14]. On the other hand, MOS is critical for protracted metaphase II arrest, but it is not required for its establishment [64, 65]. Paradoxically, MPF activity may negatively regulate the MOS pathway; Yamamoto et al. [66] showed that when MPF activity reaches a critical lower level, the c-Mos/MAPK pathway suppresses cyclin B degradation in order to elevate MPF levels, while elevation of MPF beyond a critical upper level activates cyclin B degradation.

4. Conclusion

Kisspeptin supplementation with 6-DMAP culture improved the developmental competence of oocytes activated with electric pulse and 8% ethanol. Relative quantitative analysis of the transcript showed changes associated with the efficient activation of oocytes; MOS expression was increased after electric and ionomycin activation and this effect was magnified in presence of KP in electrically activated oocytes. This could explain the difference in cleavage and blastocyst development observed in the two groups as compared with the ethanol-activated group. On the other hand, CCNB1 expression was decreased in electric and ethanol-activated oocytes treated with KP. This result might also explain the interplay between different regulatory components of calcium ions, MOS/CCNB1/MAPK pathway to exit from oocyte metaphase II arrest which in turn reflects difference in embryo cleavage, and blastocyst development observed between groups treated with the calcium modulatory peptide KP.

We suggest that KP supplementation may be adopted in the protocol for electric and ethanol activation of porcine oocyte to improve the embryonic developmental competence.


MOS:c-MOS or proto-oncogene serine/threonine-protein kinase Mos
CCNB1:G2/mitotic-specific cyclin-B1
MPF:Mitosis-promoting factor or M-Phase-promoting factor
MAPK:Mitogen-activated protein kinase
KISS1R:Kisspeptin receptor or KiSS1-derived peptide receptor or GPR54.

Additional Points

Availability of Data and Material. All data generated or analyzed during this study are included in this article. Any inquiries should be sent directed to the corresponding author.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

All authors participated in the design and implementation of this study. All authors read and approved the final manuscript. Islam M. Saadeldin and Ayman Abdel-Aziz Swelum contributed equally to this paper.


The authors extended their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through the research group project (no. RG-1438-018).


  1. K. T. Jones, J. Carroll, and D. G. Whittingham, “Ionomycin, thapsigargin, ryanodine, and sperm induced Ca2+ release increase during meiotic maturation of mouse oocytes,” The Journal of Biological Chemistry, vol. 270, no. 12, pp. 6671–6677, 1995. View at: Publisher Site | Google Scholar
  2. S. A. Stricker, “Comparative biology of calcium signaling during fertilization and egg activation in animals,” Developmental Biology, vol. 211, no. 2, pp. 157–176, 1999. View at: Publisher Site | Google Scholar
  3. M. Whitaker and R. Patel, “Calcium and cell cycle contro,” Development, vol. 108, pp. 525–542, 1990. View at: Google Scholar
  4. J. Carroll, K. T. Jones, and D. G. Whittingham, “Ca2+ release and the development of Ca2+ release mechanisms during oocyte maturation: a prelude to fertilization,” Reviews of Reproduction, vol. 1, no. 3, pp. 137–143, 1996. View at: Publisher Site | Google Scholar
  5. Y. Hashiba, Y. Asada, O. Heikinheimo, S. E. Lanzendorf, and S. Mizutani, “Microinjection of antisense c-mos oligonucleotides prevents the progression of meiosis in human and hamster oocytes,” Fertility and Sterility, vol. 76, no. 1, pp. 143–147, 2001. View at: Publisher Site | Google Scholar
  6. N. Sagata, “What does Mos do in oocytes and somatic cells?” BioEssays, vol. 19, no. 1, pp. 13–21, 1997. View at: Publisher Site | Google Scholar
  7. J. E. Ferrell Jr., “Xenopus oocyte maturation: new lessons from a good egg,” Bioessays, vol. 21, no. 10, pp. 833–842, 1999. View at: Google Scholar
  8. O. Heikinheimo, S. Lanzendorf, S. Baka, and W. Gibbons, “Cell proliferation and apoptosis: cell cycle genes c-mos and cyclin-B1 are expressed in a specific pattern in human oocytes and preimplantation embryos,” Human Reproduction, vol. 10, no. 3, pp. 699–707, 1995. View at: Publisher Site | Google Scholar
  9. A. Wehrend and B. Meinecke, “Kinetics of meiotic progression, M-phase promoting factor (MPF) and mitogen-activated protein kinase (MAP kinase) activities during in vitro maturation of porcine and bovine oocytes: species specific differences in the length of the meiotic stages,” Animal Reproduction Science, vol. 66, no. 3-4, pp. 175–184, 2001. View at: Publisher Site | Google Scholar
  10. A. Castro, M. Peter, L. Magnaghi-Jaulin et al., “Cyclin B/cdc2 induces c-Mos stability by direct phosphorylation in Xenopus oocytes,” Molecular Biology of the Cell (MBoC), vol. 12, no. 9, pp. 2660–2671, 2001. View at: Publisher Site | Google Scholar
  11. M. Frank-Vaillant, O. Haccard, R. Ozon, and C. Jessus, “Interplay between Cdc2 kinase and the c-Mos/MAPK pathway between metaphase I and metaphase II in Xenopus oocytes,” Developmental Biology, vol. 231, no. 1, pp. 279–288, 2001. View at: Publisher Site | Google Scholar
  12. O. Haccard and C. Jessus, “Redundant pathways for Cdc2 activation in Xenopus oocyte: either cyclin B or Mos synthesis,” EMBO Reports, vol. 7, no. 3, pp. 321–325, 2006. View at: Publisher Site | Google Scholar
  13. J. Ito, M. Shimada, S. Hochi, and M. Hirabayashi, “Involvement of Ca2+-dependent proteasome in the degradation of both cyclin B1 and Mos during spontaneous activation of matured rat oocytes,” Theriogenology, vol. 67, no. 3, pp. 475–485, 2007. View at: Publisher Site | Google Scholar
  14. S. Madgwick and K. T. Jones, “How eggs arrest at metaphase II: MPF stabilisation plus APC/C inhibition equals cytostatic factor,” Cell Division, vol. 2, article no. 4, 2007. View at: Publisher Site | Google Scholar
  15. D.-X. Zhang, X.-S. Cui, and N.-H. Kim, “Molecular characterization and polyadenylation-regulated expression of cyclin B1 and Cdc2 in porcine oocytes and early parthenotes,” Molecular Reproduction and Development, vol. 77, no. 1, pp. 38–50, 2010. View at: Publisher Site | Google Scholar
  16. W.-M. Cheng, X.-L. Sun, L. An et al., “Effect of different parthenogenetic activation methods on the developmental competence of in vitro matured porcine oocytes,” Animal Biotechnology, vol. 18, no. 2, pp. 131–141, 2007. View at: Publisher Site | Google Scholar
  17. S. Liu, K. Cui, H. L. Li et al., “Comparison of chemical, electrical, and combined activation methods for in vitro matured porcine oocytes,” In Vitro Cellular & Developmental Biology—Animal, vol. 51, no. 2, pp. 103–112, 2015. View at: Publisher Site | Google Scholar
  18. S. Roh and W.-S. Hwang, “In vitro development of porcine parthenogenetic and cloned embryos: comparison of oocyte-activating techniques, various culture systems and nuclear transfer methods,” Reproduction, Fertility and Development, vol. 14, no. 1-2, pp. 93–99, 2002. View at: Publisher Site | Google Scholar
  19. Y. J. Yi and C. S. Park, “Parthenogenetic development of porcine oocytes treated by ethanol, cycloheximide, cytochalasin B and 6-dimethylaminopurine,” Animal Reproduction Science, vol. 86, no. 3-4, pp. 297–304, 2005. View at: Publisher Site | Google Scholar
  20. A. Paffoni, T. A. L. Brevini, E. Somigliana, L. Restelli, F. Gandolfi, and G. Ragni, “In vitro development of human oocytes after parthenogenetic activation or intracytoplasmic sperm injection,” Fertility and Sterility, vol. 87, no. 1, pp. 77–82, 2007. View at: Publisher Site | Google Scholar
  21. C. G. Grupen, J. C. Mau, S. M. McIlfatrick, S. Maddocks, and M. B. Nottle, “Effect of 6-dimethylaminopurine on electrically activated in vitro matured porcine oocytes,” Molecular Reproduction and Development, vol. 62, no. 3, pp. 387–396, 2002. View at: Publisher Site | Google Scholar
  22. L. Liu and X. Yang, “Interplay of maturation-promoting factor and mitogen-activated protein kinase inactivation during metaphase-to-interphase transition of activated bovine oocytes,” Biology of Reproduction, vol. 61, no. 1, pp. 1–7, 1999. View at: Publisher Site | Google Scholar
  23. V. L. Nixon, M. Levasseur, A. McDougall, and K. T. Jones, “Ca2+oscillations promote APC/C-dependent cyclin B1 degradation during metaphase arrest and completion of meiosis in fertilizing mouse eggs,” Current Biology, vol. 12, no. 9, pp. 746–750, 2002. View at: Publisher Site | Google Scholar
  24. E. J. Mead, J. J. Maguire, R. E. Kuc, and A. P. Davenport, “Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system,” British Journal of Pharmacology, vol. 151, no. 8, pp. 1143–1153, 2007. View at: Publisher Site | Google Scholar
  25. F. Wahab, B. Atika, M. Shahab, and R. Behr, “Kisspeptin signalling in the physiology and pathophysiology of the urogenital system,” Nature Reviews Urology, vol. 13, no. 1, pp. 21–32, 2016. View at: Publisher Site | Google Scholar
  26. A. Caraty, J. T. Smith, D. Lomet et al., “Kisspeptin synchronizes preovulatory surges in cyclical ewes and causes ovulation in seasonally acyclic ewes,” Endocrinology, vol. 148, no. 11, pp. 5258–5267, 2007. View at: Publisher Site | Google Scholar
  27. J. M. Castellano, M. Gaytan, J. Roa et al., “Expression of KiSS-1 in rat ovary: putative local regulator of ovulation?” Endocrinology, vol. 147, no. 10, pp. 4852–4862, 2006. View at: Publisher Site | Google Scholar
  28. F. Gaytán, M. Gaytán, J. M. Castellano et al., “KiSS-1 in the mammalian ovary: distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction,” American Journal of Physiology-Endocrinology and Metabolism, vol. 296, no. 3, pp. E520–E531, 2009. View at: Publisher Site | Google Scholar
  29. C. N. Jayasena, A. Abbara, A. N. Comninos et al., “Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization,” The Journal of Clinical Investigation, vol. 124, no. 8, pp. 3667–3677, 2014. View at: Publisher Site | Google Scholar
  30. H. Matsui, Y. Takatsu, S. Kumano, H. Matsumoto, and T. Ohtaki, “Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat,” Biochemical and Biophysical Research Communications, vol. 320, no. 2, pp. 383–388, 2004. View at: Publisher Site | Google Scholar
  31. I. M. Saadeldin, O. J. Koo, J. T. Kang et al., “Paradoxical effects of kisspeptin: it enhances oocyte in vitro maturation but has an adverse impact on hatched blastocysts during in vitro culture,” Reproduction, Fertility and Development, vol. 24, no. 5, pp. 656–668, 2012. View at: Publisher Site | Google Scholar
  32. A. V. Babwah, M. Pampillo, L. Min, U. B. Kaiser, and M. Bhattacharya, “Single-cell analyses reveal that KISS1R-expressing cells undergo sustained kisspeptin-induced signaling that is dependent upon an influx of extracellular CA2+,” Endocrinology, vol. 153, no. 12, pp. 5875–5887, 2012. View at: Publisher Site | Google Scholar
  33. S. Constantin, C. S. Caligioni, S. Stojilkovic, and S. Wray, “Kisspeptin-10 facilitates a plasma membrane-driven calcium oscillator in gonadotropin-releasing hormone-1 neurons,” Endocrinology, vol. 150, no. 3, pp. 1400–1412, 2009. View at: Publisher Site | Google Scholar
  34. M.-C. Hsu, J.-Y. Wang, Y.-J. Lee, D.-S. Jong, K.-H. Tsui, and C.-H. Chiu, “Kisspeptin modulates fertilization capacity of mouse spermatozoa,” Reproduction, vol. 147, no. 6, pp. 835–845, 2014. View at: Publisher Site | Google Scholar
  35. Q. Jiang, M. He, W. K. W. Ko, and A. O. L. Wong, “Kisspeptin induction of somatolactin-α release in goldfish pituitary cells: functional role of cAMP/PKA-, PLC/PKC-, and Ca2+/calmodulin-dependent cascades,” American Journal of Physiology-Endocrinology and Metabolism, vol. 307, no. 10, pp. E872–E884, 2014. View at: Publisher Site | Google Scholar
  36. X. Liu, K. Lee, and A. E. Herbison, “Kisspeptin excites gonadotropin-releasing hormone neurons through a phospholipase C/calcium-dependent pathway regulating multiple ion channels,” Endocrinology, vol. 149, no. 9, pp. 4605–4614, 2008. View at: Publisher Site | Google Scholar
  37. L. Min, K. Soltis, A. C. S. Reis et al., “Dynamic kisspeptin receptor trafficking modulates kisspeptin-mediated calcium signaling,” Molecular Endocrinology, vol. 28, no. 1, pp. 16–27, 2014. View at: Publisher Site | Google Scholar
  38. F. M. Pinto, A. Cejudo-Román, C. G. Ravina et al., “Characterization of the kisspeptin system in human spermatozoa,” International Journal of Andrology, vol. 35, no. 1, pp. 63–73, 2012. View at: Publisher Site | Google Scholar
  39. E. W. Kuijk, L. Du Puy, H. T. A. Van Tol, H. P. Haagsman, B. Colenbrander, and B. A. J. Roelen, “Validation of reference genes for quantitative RT-PCR studies in porcine oocytes and preimplantation embryos,” BMC Developmental Biology, vol. 7, article no. 58, 2007. View at: Publisher Site | Google Scholar
  40. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at: Publisher Site | Google Scholar
  41. D.-B. Koo, J.-I. Chae, J.-S. Kim et al., “Inactivation of MPF and MAP kinase by single electrical stimulus for parthenogenetic development of porcine oocytes,” Molecular Reproduction and Development, vol. 72, no. 4, pp. 542–549, 2005. View at: Publisher Site | Google Scholar
  42. Y.-L. Miao and C. J. Williams, “Calcium signaling in mammalian egg activation and embryo development: the influence of subcellular localization,” Molecular Reproduction and Development, vol. 79, no. 11, pp. 742–756, 2012. View at: Publisher Site | Google Scholar
  43. T. Ducibella, D. Huneau, E. Angelichio et al., “Egg-to-embryo transition is driven by differential responses to Ca2+ oscillation number,” Developmental Biology, vol. 250, no. 2, pp. 280–291, 2002. View at: Publisher Site | Google Scholar
  44. J. G. Knott, A. J. Gardner, S. Madgwick, K. T. Jones, C. J. Williams, and R. M. Schultz, “Calmodulin-dependent protein kinase II triggers mouse egg activation and embryo development in the absence of Ca2+ oscillations,” Developmental Biology, vol. 296, no. 2, pp. 388–395, 2006. View at: Publisher Site | Google Scholar
  45. G.-S. Im, M. Samuel, L. Lai, Y. Hao, and R. S. Prather, “Development and calcium level changes in pre-implantation porcine nuclear transfer embryos activated with 6-DMAP after fusion,” Molecular Reproduction and Development, vol. 74, no. 9, pp. 1158–1164, 2007. View at: Publisher Site | Google Scholar
  46. C. L. V. Leal and L. Liu, “Differential effects of kinase inhibitor and electrical stimulus on activation and histone H1 kinase activity in pig oocytes,” Animal Reproduction Science, vol. 52, no. 1, pp. 51–61, 1998. View at: Publisher Site | Google Scholar
  47. D. R. Hagen, R. S. Prather, and N. L. First, “Response of porcine oocytes to electrical and chemical activation during maturation in vitro,” Molecular Reproduction and Development, vol. 28, no. 1, pp. 70–73, 1991. View at: Publisher Site | Google Scholar
  48. R. Alberio, V. Zakhartchenko, J. Motlik, and E. Wolf, “Mammalian oocyte activation: lessons from the sperm and implications for nuclear transfer,” The International Journal of Developmental Biology, vol. 45, no. 7, pp. 797–809, 2001. View at: Google Scholar
  49. R. S. Prather, “Basic mechanisms of fertilization and parthenogenesis in pigs,” Reprod Supp, vol. 58, pp. 105–112, 2001. View at: Google Scholar
  50. R. A. Fissore and J. M. Robl, “Intracellular CA2+ response of rabbit oocytes to electrical stimulation,” Molecular Reproduction and Development, vol. 32, no. 1, pp. 9–16, 1992. View at: Publisher Site | Google Scholar
  51. L. F. Rickords and K. L. White, “Electrofusion‐induced intracellular Ca2+ flux and its effect on murine oocyte activation,” Molecular Reproduction and Development, vol. 31, no. 2, pp. 152–159, 1992. View at: Publisher Site | Google Scholar
  52. P. Loi, S. Ledda, J. Fulka Jr., P. Cappai, and R. M. Moor, “Development of parthenogenetic and cloned ovine embryos: effect of activation protocols,” Biology of Reproduction, vol. 58, no. 5, pp. 1177–1187, 1998. View at: Publisher Site | Google Scholar
  53. N. T. Ruddock, Z. Machaty, M. Milanick, and R. S. Prather, “Mechanism of intracellular pH increase during parthenogenetic activation of in vitro matured porcine oocytes,” Biology of Reproduction, vol. 63, no. 2, pp. 488–492, 2000. View at: Publisher Site | Google Scholar
  54. J. L. Susko-Parrish, M. L. Leibfried-Rutledge, D. L. Northey, V. Schutzkus, and N. L. First, “Inhibition of protein kinases after an induced calcium transient causes transition of bovine oocytes to embryonic cycles without meiotic completion,” Developmental Biology, vol. 166, no. 2, pp. 729–739, 1994. View at: Publisher Site | Google Scholar
  55. M. J. Whitaker and R. A. Steinhardt, “Ionic regulation of egg activation,” Quarterly Reviews of Biophysics, vol. 15, no. 4, pp. 593–666, 1982. View at: Publisher Site | Google Scholar
  56. L. Sun and K. Machaca, “Ca2+cyt negatively regulates the initiation of oocyte maturation,” The Journal of Cell Biology, vol. 165, no. 1, pp. 63–75, 2004. View at: Publisher Site | Google Scholar
  57. R. De La Fuente and W. A. King, “Developmental consequences of karyokinesis without cytokinesis during the first mitotic cell cycle of bovine parthenotes,” Biology of Reproduction, vol. 58, no. 4, pp. 952–962, 1998. View at: Publisher Site | Google Scholar
  58. L. E. Rajagopalan and J. S. Malter, “Turnover and translation of in vitro synthesized messenger RNAs in transfected, normal cells,” The Journal of Biological Chemistry, vol. 271, no. 33, pp. 19871–19876, 1996. View at: Publisher Site | Google Scholar
  59. R. Wisdom and W. Lee, “The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors,” Genes & Development, vol. 5, no. 2, pp. 232–243, 1991. View at: Publisher Site | Google Scholar
  60. A. Wodnar-Filipowicz and C. Moroni, “Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions.,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 87, no. 2, pp. 777–781, 1990. View at: Publisher Site | Google Scholar
  61. D. Zhang, X. Li, S. Sun, X. Shen, X. Cui, and N. Kim, “Involvement of ER-calreticulin-Ca2+ signaling in the regulation of porcine oocyte meiotic maturation and maternal gene expression,” Molecular Reproduction and Development, vol. 77, no. 5, pp. 462–471, 2010. View at: Publisher Site | Google Scholar
  62. T. Lorca, F. H. Cruzalegui, D. Fesquet et al., “Calmodulin-dependent protein kinase II mediates inactivation of MPF and CSF upon fertilization of xenopus eggs,” Nature, vol. 366, no. 6452, pp. 270–273, 1993. View at: Publisher Site | Google Scholar
  63. S. Lazar, D. Galiani, and N. Dekel, “cAMP-dependent PKA negatively regulates polyadenylation of c-mos mRNA in rat oocytes,” Molecular Endocrinology, vol. 16, no. 2, pp. 331–341, 2002. View at: Publisher Site | Google Scholar
  64. N. Hashimoto, N. Watanabe, Y. Furuta et al., “Erratum: Parthenogenetic activation of oocytes in c-mos-deficient mice,” Nature, vol. 370, pp. 68–71, 1994. View at: Publisher Site | Google Scholar
  65. M.-H. Verlhac, J. Z. Kubiak, M. Weber et al., “Mos is required for MAP kinase activation and is involved in microtubule organization during meiotic maturation in the mouse,” Development, vol. 122, no. 3, pp. 815–822, 1996. View at: Google Scholar
  66. T. M. Yamamoto, M. Iwabuchi, K. Ohsumi, and T. Kishimoto, “APC/C-Cdc20-mediated degradation of cyclin B participates in CSF arrest in unfertilized Xenopus eggs,” Developmental Biology, vol. 279, no. 2, pp. 345–355, 2005. View at: Publisher Site | Google Scholar

Copyright © 2018 Islam M. Saadeldin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

846 Views | 223 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder
 Sign up for content alertsSign up

You are browsing a BETA version of Click here to switch back to the original design.